The quality of medication information in Australia: the need for more clinical expertise and accountability

Caroline E Bulsara and Anne McKenzie
Med J Aust 2009; 191 (3): . || doi: 10.5694/j.1326-5377.2009.tb02740.x
Published online: 3 August 2009

To the Editor: We agree with Stockigt that clinical accountability is needed in the production of consumer medicines information (CMI).1 However, providing CMI is a great deal more complex. The ways in which consumers access and absorb medical information are still largely unknown, and the most important issue is potentially that consumers are not receiving CMI.

  • Caroline E Bulsara
  • Anne McKenzie

  • University of Western Australia, Perth, WA.



We acknowledge the input of the expert panel throughout the course of the study and funding for the study from the NHMRC.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.